| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |